meRfi®-GM
Carcinogenesis / Oncogenesis / Tumorigenesis
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Tumor cells during oncogenesis display unique carbohydrate chains, presenting new targets for cancer immunotherapy.
Mantuano et al. 2020
Although carcinogenesis is defined by de novo genetic alterations, its sustained progression is dependent upon its ability to evade the host’s immunity
Carcinogenesis refers to the complex, multi-step process by which normal cells transform into canc…
References (Sources)
- Adenoma-linked barrier defects and microbial products drive IL-23/ IL-17-mediated tumor growth
- Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion
- Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy
- Interactions between the tumor suppressor p53 and immune responsesReview
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
- Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy